Julie Leca

Université Claude Bernard Lyon 1 — France

Medicine · Health Sciences

11h-index1.1kcitations35works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(15), Cancer, Hypoxia, and Metabolism(9), Cancer Research and Treatments(8), Glioma Diagnosis and Treatment(5), Acute Myeloid Leukemia Research(5)

Publications35 total

A human pathophysiological 3D-bone marrow model reveals immune and stromal cell heterogeneity
Communications Biology·2026Open Access
Mutant <i>IDH1</i> cooperates with <i>NPM1c</i> or <i>FLT3</i> <sup>ITD</sup> to drive distinct myeloid diseases and molecular outcomes
Proceedings of the National Academy of Sciences·2025· 2 citedOpen Access
Abstract SY16-01: What IDH mouse models have taught us about hematological diseases, from leukemia to T cell lymphoma
Cancer Research·2024
Abstract A16: Multi-omic analyses in genetically engineered mice reveal distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
Blood Cancer Discovery·2023
Supplementary data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S2 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S2 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S5 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S1 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S1 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S5 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S4 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S3 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S4 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Supplementary data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S3 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment
Cancer Cell·2023· 54 citedOpen Access
Distinct and opposite effects of leukemogenic <i>Idh</i> and <i>Tet2</i> mutations in hematopoietic stem and progenitor cells
Proceedings of the National Academy of Sciences·2023· 20 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Richard Tomasini(24), Sophie Vasseur(24), Juan Iovanna(23), Jérémy Nigri(22), Fabienne Guillaumond(21), Sophie Lac(20), Véronique Secq(19), Marie‐Noëlle Lavaut(18), Christian Bressy(18), Mehdi Ouaïssi(18), Julie Roques(17), Daniel Pietrasz(17), Samuel Granjeaud(17), Jean‐Baptiste Bachet(17), Thi-Thien Bui(15), Tak W. Mak(7), Nelson Dusetti(6), Jérôme Fortin(6), Thorsten Berger(6), Céline Loncle(4)